Figure 1. In vivo shRNA discovery of immunotherapy targets. T cells infected with shRNA libraries were injected into mice with melanoma. Several days later, T cells were purified from tumors and secondary lymphoid tissue. Deep sequencing then identified shRNAs that enabled T cells to preferentially accumulate and proliferate in tumors more so than in spleens. (Figure based on Figure 1 in ref. 1.)